United States Cancer Vaccine Market Product, Application, End-User Industry, and Geography - Global Forecast to 2025


26th September 2018 - United States Cancer Vaccines Market is expected to grow at a significant CAGR in the upcoming years as the scope, product types, and its applications are increasing across the globe. Vaccines come across as remedies that stimulate the immune system of the body to defend against foreign substances. The stimulated immune system kills foreign bodies. Vaccines work on the principle of recalling foreign element and avoid contamination likely to be produced by this foreign particle when it attacks again.



Additionally, cancer vaccines enhance body’s natural immune system to fight against cancer cells. Cancer treatment vaccines abolish cancer cells left in the body after the other treatments, stop cancer from recurring, and stop additional spreading of cancer. Cancer vaccines could be directed intravenously in adults as well as in children.


The factors that drive the growth of Cancer Vaccines are growing technological development, increasing cancer cases, rising innovations pertaining to cancer, increasing government initiatives, growing aged population in the region. On the other hand, the factors that hamper the growth of Cancer Vaccines are Stringent rules and regulation procedures of governments, Cold chain, or lack of temperature-controlled supply chain management, less accessibility to vaccines in the remote regions.

United States Cancer Vaccines Market is categorized based on product type, applications, and geography. United States Cancer Vaccines Market is categorized based on product types such as Prophylactic Vaccines, Therapeutic Vaccines. United States Cancer Vaccines Market is categorized based on application to Adults, Children. United States Cancer Vaccines Market is categorized based on geography into The West, The Southwest, The Middle Atlantic, New England, The South and The Midwest.

Some of the key players that fuel the growth of the United States Cancer Vaccines Market include Merck, Sanofi, Galena Biopharma, Amgen, Isa Pharmaceuticals, Bristol-Myers Squibb, Bavarian Nordic, GlaxoSmithKline, Inovio Pharmaceuticals, Antigen Express, Biothera, Prima BioMed, Juvaris Biotherapeutics, Provectus Biopharmaceuticals, Dendreon, Oxford BioMedica, Celldex Therapeutics, Aduro BioTech, Northwest Biotherapeutics, Vaxon Biotech. The key players are focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.

Market Segment:

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest

with sales (volume), revenue (value), market share and growth rate of Cancer Vaccine in these regions, from 2013 to 2025 (forecast).

United States Cancer Vaccine market competition by top manufacturers/players, with Cancer Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Dendreon Corporation
• NeoStem Oncology
• ImmunoGen
• Inovio Pharmaceuticals
• Novartis




Comments

Popular posts from this blog

Gardening Equipment Market Scope, Demands, Technological Development and Competitive Insights to 2025

Squalene Industry In-depth Analysis and Forecast Report, 2030

Thrust Vector Control System (TVC) Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025